News

MSD’s investigational KRAS G12C inhibitor has shown signs of anti-tumour activity when used both alone and in combination ...
Zilovertamab vedotin, an antibody drug conjugate (ADC) developed by Merck & Co (MSD) to treat diffuse large B-cell lymphoma ...
Louisville MSD customers in Jefferson and Oldham counties could see higher prices starting in Summer 2025.
Daiichi Sankyo and MSD have voluntarily withdrawn the biologics licence application (BLA) in the US for their HER3-directed ...
For the new graduates at the Maryland School for the Deaf, Friday’s commencement ceremony was the culmination of a year of big plans and accomplishments. The school’s theme for the past year was ...
The Louisville MSD Board approved a preliminary rate increase Tuesday, saying it's going to protect public health, property ...
CASE, PLEASE CALL THAT POLICE TIP LINE. LOUISVILLE’S MSD BOARD HAS APPROVED A WASTEWATER RATE INCREASE WHICH WILL AFFECT RESIDENTS IN JEFFERSON AND OLDHAM COUNTIES. SO HOW MUCH ARE WE TALKING ABOUT?
Daiichi Sankyo and MSD have announced the first subject dosing in the Phase III Ideate-Esophageal01 trial, assessing the ...
There will now be a 30-day comment period and the board will vote on the final rate resolution on July 28, with the rates taking effect for Jefferson County on Aug. 1, if approved.
Dutta’s move mirrors a broader shift in India’s corporate landscape, one where seasoned professionals are stepping out to ...
A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by ...
Louisville MSD board members voted to approve a preliminary rate increase. If approved, the rate increase would add $3.91 to the average monthly bill for customers in Jefferson County and $1.57 ...